Family · Pharmaceutical analytical standards
Saredutant
A tachykinin NK2 receptor antagonist, studied as a new antidepressant and anxiolytic: it reached phase III trials for major depression, and its development was stopped in 2009. This family brings together the active ingredient.
Did you know?The receptor it blocks responds to neurokinin A, also called substance K, a neuropeptide of the tachykinin family; in humans the NK2 receptor is abundant in the stomach and in the muscle of the gut and uterus.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
